Education
About Us
Working with TipRanks
Follow Us
Capstone Therapeutics Corp (CAPS)
NASDAQ:CAPS
CAPS Stock Chart & Stats
$0.71
$0.51(22.77%)
At close: 4:00 PM EST
$0.71
$0.51(22.77%)
Day’s Range― - ―
52-Week Range$0.73 - $16.18
Previous CloseN/A
Volume2.10K
Average Volume (3M)1.37M
Market Cap
$5.85M
Enterprise Value$29.73M
Total Cash (Recent Filing)$730.00K
Total Debt (Recent Filing)$23.25M
Price to Earnings (P/E)―
Beta1.27
Next Earnings
Apr 07, 2026EPS Estimate
-0.14Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.13
Shares Outstanding8,306,205
10 Day Avg. Volume1,309,522
30 Day Avg. Volume1,370,765
Financial Highlights & Ratios
PEG Ratio0.03
Price to Book (P/B)-0.12
Price to Sales (P/S)0.00787
P/FCF Ratio0.10
Enterprise Value/Market Cap5.08
Enterprise Value/Revenue0.66
Enterprise Value/Gross Profit3.04
Enterprise Value/Ebitda-10.39
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Capstone Therapeutics News
CAPS FAQ
What was Capstone Therapeutics Corp’s price range in the past 12 months?
Capstone Therapeutics Corp lowest stock price was $0.72 and its highest was $16.18 in the past 12 months.
What is Capstone Therapeutics Corp’s market cap?
Capstone Therapeutics Corp’s market cap is $5.85M.
When is Capstone Therapeutics Corp’s upcoming earnings report date?
Capstone Therapeutics Corp’s upcoming earnings report date is Apr 07, 2026 which is in 98 days.
How were Capstone Therapeutics Corp’s earnings last quarter?
Capstone Therapeutics Corp released its earnings results on Aug 19, 2025. The company reported -$0.13 earnings per share for the quarter, missing the consensus estimate of -$0.07 by -$0.06.
Is Capstone Therapeutics Corp overvalued?
According to Wall Street analysts Capstone Therapeutics Corp’s price is currently Overvalued.
Does Capstone Therapeutics Corp pay dividends?
Capstone Therapeutics Corp does not currently pay dividends.
What is Capstone Therapeutics Corp’s EPS estimate?
Capstone Therapeutics Corp’s EPS estimate is -0.14.
How many shares outstanding does Capstone Therapeutics Corp have?
Capstone Therapeutics Corp has 8,306,205 shares outstanding.
What happened to Capstone Therapeutics Corp’s price movement after its last earnings report?
Capstone Therapeutics Corp reported an EPS of -$0.13 in its last earnings report, missing expectations of -$0.07. Following the earnings report the stock price went down -4.386%.
Which hedge fund is a major shareholder of Capstone Therapeutics Corp?
Currently, no hedge funds are holding shares in CAPS
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Capstone Therapeutics Corp
Capstone Therapeutics (CAPS) is a biotechnology company focused on developing innovative therapies for serious medical conditions. The company operates primarily in the healthcare sector, specializing in the research and development of biologics and pharmaceuticals aimed at treating diseases with significant unmet medical needs. Capstone's core products include advanced therapeutic candidates designed to enhance patient outcomes and improve the quality of life in various therapeutic areas, such as oncology and autoimmune disorders.
Technical Analysis
Ownership Overview
―
Insiders
0.05% Mutual Funds
0.14% Other Institutional Investors
99.81% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---